Top Five Radiology Content for September 2024

News
Slideshow

Catch up on the most-well viewed radiology content in September 2024.

Touching on a variety of topics in radiology, ranging from new research on an emerging PET/CT agent for detecting clear cell renal cell carcinoma to current insights in evaluating pelvic endometriosis, here are the top five most well-viewed content from Diagnostic Imaging for September 2024.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Related Content
Ultrasound-Based Nomogram May Enhance Risk Stratification for Thyroid Nodules with Peripheral Calcifications

Ultrasound-Based Nomogram May Enhance Risk Stratification for Thyroid Nodules with Peripheral Calcifications

Jeff Hall
May 20th 2025
Article

Incorporating six independent predictive factors for malignant thyroid nodules with peripheral calcifications, an emerging ultrasound-based nomogram provided an 88.2 percent AUC in validation testing.

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

Jeff Hall
March 18th 2025
Podcast

In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.

Ten Takeaways from New Guidelines on Pre-Op MRI for Fertility-Sparing Treatments of Cervical, Endometrial and Ovarian Cancer

Ten Takeaways from New Guidelines on Pre-Op MRI for Fertility-Sparing Treatments of Cervical, Endometrial and Ovarian Cancer

Jeff Hall
May 19th 2025
Article

New guidelines from the European Society of Urogenital Radiology (ESUR) offer pertinent principles and recommendations for MRI use in considering fertility-sparing treatments for women with ovarian, endometrial, or cervical cancer.

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

Matt Hoffman
July 3rd 2021
Podcast

An interview with two experts to discuss newly released guidance for using standardized MRI protocols for patients with this condition.

What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence

What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence

Jeff Hall
May 16th 2025
Article

For patients at high-risk for biochemical recurrence of prostate cancer, PSMA PET/CT findings revealed that 77 percent had one or more prostate lesions after undergoing local radiation therapy or radical prostatectomy, according to a recent study.

BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound

BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound

Jeff Hall
May 14th 2025
Article

The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.

© 2025 MJH Life Sciences

All rights reserved.